Oruka Therapeutics, Inc. · NASDAQ:ORKA
Goncalves Joana sold 7,947 Oruka Therapeutics, Inc. shares (Form 4)
Traded Jun 15, 2026 · Filed Jun 15, 2026
On Jun 15, 2026, Goncalves Joana (Chief Medical Officer) sold 7,947 Oruka Therapeutics, Inc. shares at an average US$69.28 for US$551K under a trading plan, leaving 32,718 shares. Filed Jun 15, 2026 (Form 4).
- Sold
- 7,947 shares
- Price
- US$69.28 average (US$68.38 to US$70.62)
- Value
- US$551K
- Holding after
- 32,718 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | Common Stock | Option exercise | 3,500 | US$6.84 | 37,165 | Direct |
| Jun 15, 2026 | Common Stock | Option exercise | 3,500 | US$7.80 | 40,665 | Direct |
| Jun 15, 2026 | Common Stock | Sale | 1,636 | US$68.38 | 39,029 | Direct |
| Jun 15, 2026 | Common Stock | Sale | 5,064 | US$69.42 | 33,965 | Direct |
| Jun 15, 2026 | Common Stock | Sale | 300 | US$70.62 | 33,665 | Direct |
| Jun 15, 2026 | Common Stock | Sale | 947 | US$69.69 | 32,718 | Direct |
Source
Related
- Oruka Therapeutics, Inc.
- Goncalves Joana
- Oruka Therapeutics, Inc. shareholders
- Form 4 · Goncalves Joana · Oct 15, 2026
- Form 4 · Goncalves Joana · Sep 15, 2026
- Form 4 · Goncalves Joana · Aug 17, 2026
- Form 4 · Goncalves Joana · Jul 15, 2026
- Form 4 · Goncalves Joana · May 15, 2026
- Form 4 · Quinlan Paul T · Oct 20, 2026
- Form 4 · Agarwal Arjun · Oct 13, 2026
- Form 4 · Klein Lawrence Otto · Oct 2, 2026
- Form 4 · Quinlan Paul T · Sep 21, 2026
- Form 4 · Agarwal Arjun · Sep 21, 2026